This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

edited by Roy Lawson Tawes, Jr, MD, 407 pp, with illus, ISBN 1-56757-061-5, Grosse Pointe, Mich, Gregory Appleton Publishers, 1997.

Arch Surg. 1999;134:1153.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As a surgeon, one need not look far to see the rapidly growing interest and new trends in blood product management. Because of the relatively recent dramas of human immunodeficiency virus and hepatitis C, there is, not surprisingly, great interest in avoiding both known and yet to be discovered infectious agents. In addition, it has become increasingly clear that allogeneic transfusions carry significant immunologic consequences that would best be avoided. As observed in the first pages of this text, two thirds of the 12 million U of blood transfused annually in the United States are used for surgery. Preoperative donation is already a mandate and salvage strategies are becoming the standard of care. Thus, it is clearly appropriate that surgeons be not only well informed on this subject but also actively involved in this new technology. Autotransfusion: Therapeutic Principles and Trends, edited by Roy Lawson Tawes, Jr, MD, with . . . [Full Text of this Article]